Skip to Content

An integrated financial technology (fintech) platform designed to transform both the practice and patient experience.

Learn More

Powering Prestige Experiences in Aesthetics with Products and Services Portfolio

The HintMD platform provides a seamless, simple and smart payment solution that empowers aesthetic practices to improve practice management, practice economics and practice loyalty.

Visit HintMD.com

Acquisition provides Revance access to a $500M+ opportunity in U.S. aesthetic practice payment services 1

Products and Services

DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA and is currently under regulatory review.

Powering Prestige Practice and Patient Experiences

Vertically-integrated payments platform for medical aesthetic practices

Patient subscriptions and practice loyalty programs improve practice economics

Advances Revance Aesthetics’ vision to improve outcomes for patients and practices

HintMD’s Integrated Platform

Transforms Revance Aesthetics Commercial Footprint

Leverages commercial infrastructure

Adds experienced fintech talent to:
• Expand our digital capabilities
• Address practice and patient desires for a loyalty program
• Add features and capabilities to the platform over time

Creates near-term value with recurring revenue

Aligns with Revance Aesthetics’ vision to build a prestige aesthetics category that transforms patients and practice experiences

Daring to make a difference with products and services to deliver meaningful outcomes to our customers

References

  1. Data on File, IBIS, ISAPS, AmSpa

  2. RHA® is a trademark of TEOXANE SA.

Back to top